Skip to main content

Navigation group

Type at least 3 characters
241 articles

Articles

Original Research

Published on 05 Feb 2021

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

in Pediatric Hematology and Hematological Malignancies

  • Nerea Vega-García
  • Sara Perez-Jaume
  • Elena Esperanza-Cebollada
  • Clara Vicente-Garcés
  • Montserrat Torrebadell
  • Antonio Jiménez-Velasco
  • Margarita Ortega
  • Marta Llop
  • Lorea Abad
  • José Manuel Vagace
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
Frontiers in Pediatrics
doi 10.3389/fped.2020.614521
  • 4,806 views
  • 6 citations